Study: Clopidogrel Monotherapy Linked to Lower MACE and Bleeding Risks vs. Aspirin After PCI
Summary
A nationwide cohort study published in JACC: Asia found that among stable patients who underwent PCI, transitioning to clopidogrel monotherapy was associated with lower risks of major adverse cardiovascular events (MACE) and major bleeding compared with aspirin monotherapy. The study, led by Jun Hwan Cho, MD, used the Korean nationwide claims and health examination database to analyze long-term outcomes from 2009 to 2019.
Source
Key quotes
· 1 pulledClopidogrel monotherapy was associated with lower risks of major adverse cardiovascular events (MACE) and major bleeding compared with aspirin monotherapy among stable patients post PCI, according to a nationwide cohort study published June 15 in JACC: Asia.
You might also wanna read
Cannabis use linked to higher heart attack risk, two new studies confirm
Two new studies presented at the American College of Cardiology's Annual Scientific Session reveal that cannabis users face a substantially
Low-Dose Aspirin Usage for Primary Prevention of Cardiovascular Disease Has Fallen by More Than Half Since 2018

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
Positive link between cannabis use and 'Major Adverse Cardiovascular Events'
Study Compares Every-Third-Day vs Daily Low-Dose Aspirin Effects on Thromboxane Inhibition
This study compares the effectiveness of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in health
Navigating NSAID safety in early pregnancy: Challenges in interpreting congenital malformation risk
This Perspective article by Yuen and Man discusses the challenges of interpreting research on NSAID safety during early pregnancy, particula

Comments
Sign in to join the conversation.
No comments yet. Be the first.